Fetal Therapy in 2011: A Review
Keywords:
No KeywordAbstract
No Abstract
References
1. Hutter D, Silverman ED, Jaeggi ET. The benefits of transplacental treatข-
ment of isolated congenital complete heart block associated with maternal
anti-Ro/SSA antibodies: a review. Scand J Immunol. 2010 Sep;72(3):235-
41.
2. Maeno Y, Hirose A, Kanbe T, Hori D. Fetal arrhythmia: prenatal diagnosis
and perinatal management. J Obstet Gynaecol Res. 2009 Aug;35(4):623-9.
3. Eliasson H, Wahren-Herlenius M, Sonesson SE. Mechanisms in fetal
bradyarrhythmia: 65 cases in a single center analyzed by Doppler flow
echocardiographic techniques. Ultrasound Obstet Gynecol. 2011 Feb;37
(2):172-8.
4. Abuhamad AZ, Fisher DA, Warsof SL, Slotnick RN, Pyle PG, Wu SY, et al.
Antenatal diagnosis and treatment of fetal goitrous hypothyroidism: case
report and review of the literature. Ultrasound Obstet Gynecol. 1995 Nov;6
(5):368-71.
5. Gruner C, Kollert A, Wildt L, Dorr HG, Beinder E, Lang N. Intrauterine
treatment of fetal goitrous hypothyroidism controlled by determination
of thyroid-stimulating hormone in fetal serum. A case report and review
of the literature. Fetal Diagn Ther. 2001 Jan-Feb;16(1):47-51.
6. Mercà Fernéndez-Balsells M, Muthusamy K, Smushkin G, Lampropulos
JF, Elamin MB, Abu Elnour NO, et al. Prenatal dexamethasone use for
the prevention of virilization in pregnancies at risk for classical congenital
adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a
systematic review and meta-analyses. Clin Endocrinol (Oxf). 2010 Oct;73
(4):436-44.
7. Vos AA, Bruinse HW. Congenital adrenal hyperplasia: do the benefits of
prenatal treatment defeat the risks? Obstet Gynecol Surv. 2010 Mar;65
(3):196-205.
8. Dejneka NS, Surace EM, Aleman TS, Cideciyan AV, Lyubarsky A,
Savchenko A, et al. In utero gene therapy rescues vision in a murine
model of congenital blindness. Mol Ther. 2004 Feb;9(2):182-8.
9. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, et al.
Successful transduction of liver in hemophilia by AAV-Factor IX and
limitations imposed by the host immune response. Nat Med. 2006 Mar;12
(3):342-7.
10. Renda MC, Maggio A. In Utero Haematopoietic Stem Cell Transplantation
(IUHSCT). Mediterr J Hematol Infect Dis 2009;1:e2009031.
11. Wataganara T, Wiwanichayakul B, Ruengwuttilert P, Sunsaneevithayakul P,
Viboonchart S, Wantanasiri C. Noninvasive diagnosis of fetal anemia and
fetal intravascular transfusion therapy: experiences at Siriraj Hospital. J
Med Assoc Thai. 2006 Jul;89(7):1036-43.
12. Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan
C. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia
to non-immune cases of thrombocytopenia. Pediatr Blood Cancer.
2005 Aug;45(2):176-83.
13. Daffos F, Forestier F, Muller JY, Reznikoff-Etievant M, Habibi B, Capella-
Pavlovsky M, et al. Prenatal treatment of alloimmune thrombocytopenia.
Lancet. 1984 Sep 15;2(8403):632.
14. Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U. Antenatal
treatment of neonatal alloimmune thrombocytopenia. N Engl J Med. 1988
Nov 24;319(21):1374-8.
15. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic
laser surgery versus serial amnioreduction for severe twin-to-twin transfusion
syndrome. N Engl J Med. 2004 Jul 8;351(2):136-44.
16. Wataganara T, Chanprapaph P, Chuangsuwanich T, Kanokpongsakdi S,
Chuenwattana P, Titapant V. Reverse twin-twin transfusion syndrome
after fetoscopic laser photocoagulation of chorionic anastomoses: a case
report. Fetal Diagn Ther. 2009;26(2):111-4.
17. Matsui H, Gardiner H. Fetal intervention for cardiac disease: the cutting
edge of perinatal care. Semin Fetal Neonatal Med. 2007 Dec;12(6):482-9.
18. Rintoul NE, Sutton LN, Hubbard AM, Cohen B, Melchionni J, Pasquariello
PS, et al. A new look at myelomeningoceles: functional level, vertebral
level, shunting, and the implications for fetal intervention. Pediatrics.
2002 Mar;109(3):409-13.
19. Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson
MP, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele.
N Engl J Med. 2011 Mar 17;364(11):993-1004.
20. Wataganara T, Ngerncham S, Kitsommart R, Fuangtharnthip P. Fetal neck
myofibroma. J Med Assoc Thai. 2007 Feb;90(2):376-80.
21. Kunisaki SM, Fauza DO, Barnewolt CE, Estroff JA, Myers LB, Bulich LA,
et al. Ex utero intrapartum treatment with placement on extracorporeal
membrane oxygenation for fetal thoracic masses. J Pediatr Surg. 2007
Feb;42(2):420-5.
22. Adzick NS. Open fetal surgery for life-threatening fetal anomalies. Semin
Fetal Neonatal Med. 2010 Feb;15(1):1-8.
23. Galinkin JL, Gaiser RR, Cohen DE, Crombleholme TM, Johnson M,
Kurth CD. Anesthesia for fetoscopic fetal surgery: twin reverse arterial
perfusion sequence and twin-twin transfusions syndrome. Anesth Analg.
2000 Dec;91(6):1394-7.
24. Rosen MA. Anesthesia for fetal procedures and surgery. Yonsei Med J.
2001 Dec;42(6):669-80.
25. Myers LB, Bulich LA, Hess P, Miller NM. Fetal endoscopic surgery:
indications and anaesthetic management. Best Pract Res Clin Anaesthesiol.
2004 Jun;18(2):231-58.
26. Schwartz DA, Moriarty KP, Tashjian DB, Wool RS, Parker RK, Markenson
GR, et al. Anesthetic management of the exit (ex utero intrapartum treatment)
procedure. J Clin Anesth. 2001 Aug;13(5):387-91.
27. Gaiser RR, Cheek TG, Kurth CD. Anesthetic management of cesarean
delivery complicated by ex utero intrapartum treatment of the fetus. Anesth
Analg. 1997 May;84(5):1150-3.
28. George RB, Melnick AH, Rose EC, Habib AS. Case series: Combined
spinal epidural anesthesia for Cesarean delivery and ex utero intrapartum
treatment procedure. Can J Anaesth. 2007 Mar;54(3):218-22.
29. Chang LC, Kuczkowski KM. The ex utero intrapartum treatment procedure:
anesthetic considerations. Arch Gynecol Obstet. 2008 Jan;277(1):83-5.
ment of isolated congenital complete heart block associated with maternal
anti-Ro/SSA antibodies: a review. Scand J Immunol. 2010 Sep;72(3):235-
41.
2. Maeno Y, Hirose A, Kanbe T, Hori D. Fetal arrhythmia: prenatal diagnosis
and perinatal management. J Obstet Gynaecol Res. 2009 Aug;35(4):623-9.
3. Eliasson H, Wahren-Herlenius M, Sonesson SE. Mechanisms in fetal
bradyarrhythmia: 65 cases in a single center analyzed by Doppler flow
echocardiographic techniques. Ultrasound Obstet Gynecol. 2011 Feb;37
(2):172-8.
4. Abuhamad AZ, Fisher DA, Warsof SL, Slotnick RN, Pyle PG, Wu SY, et al.
Antenatal diagnosis and treatment of fetal goitrous hypothyroidism: case
report and review of the literature. Ultrasound Obstet Gynecol. 1995 Nov;6
(5):368-71.
5. Gruner C, Kollert A, Wildt L, Dorr HG, Beinder E, Lang N. Intrauterine
treatment of fetal goitrous hypothyroidism controlled by determination
of thyroid-stimulating hormone in fetal serum. A case report and review
of the literature. Fetal Diagn Ther. 2001 Jan-Feb;16(1):47-51.
6. Mercà Fernéndez-Balsells M, Muthusamy K, Smushkin G, Lampropulos
JF, Elamin MB, Abu Elnour NO, et al. Prenatal dexamethasone use for
the prevention of virilization in pregnancies at risk for classical congenital
adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a
systematic review and meta-analyses. Clin Endocrinol (Oxf). 2010 Oct;73
(4):436-44.
7. Vos AA, Bruinse HW. Congenital adrenal hyperplasia: do the benefits of
prenatal treatment defeat the risks? Obstet Gynecol Surv. 2010 Mar;65
(3):196-205.
8. Dejneka NS, Surace EM, Aleman TS, Cideciyan AV, Lyubarsky A,
Savchenko A, et al. In utero gene therapy rescues vision in a murine
model of congenital blindness. Mol Ther. 2004 Feb;9(2):182-8.
9. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, et al.
Successful transduction of liver in hemophilia by AAV-Factor IX and
limitations imposed by the host immune response. Nat Med. 2006 Mar;12
(3):342-7.
10. Renda MC, Maggio A. In Utero Haematopoietic Stem Cell Transplantation
(IUHSCT). Mediterr J Hematol Infect Dis 2009;1:e2009031.
11. Wataganara T, Wiwanichayakul B, Ruengwuttilert P, Sunsaneevithayakul P,
Viboonchart S, Wantanasiri C. Noninvasive diagnosis of fetal anemia and
fetal intravascular transfusion therapy: experiences at Siriraj Hospital. J
Med Assoc Thai. 2006 Jul;89(7):1036-43.
12. Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan
C. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia
to non-immune cases of thrombocytopenia. Pediatr Blood Cancer.
2005 Aug;45(2):176-83.
13. Daffos F, Forestier F, Muller JY, Reznikoff-Etievant M, Habibi B, Capella-
Pavlovsky M, et al. Prenatal treatment of alloimmune thrombocytopenia.
Lancet. 1984 Sep 15;2(8403):632.
14. Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U. Antenatal
treatment of neonatal alloimmune thrombocytopenia. N Engl J Med. 1988
Nov 24;319(21):1374-8.
15. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic
laser surgery versus serial amnioreduction for severe twin-to-twin transfusion
syndrome. N Engl J Med. 2004 Jul 8;351(2):136-44.
16. Wataganara T, Chanprapaph P, Chuangsuwanich T, Kanokpongsakdi S,
Chuenwattana P, Titapant V. Reverse twin-twin transfusion syndrome
after fetoscopic laser photocoagulation of chorionic anastomoses: a case
report. Fetal Diagn Ther. 2009;26(2):111-4.
17. Matsui H, Gardiner H. Fetal intervention for cardiac disease: the cutting
edge of perinatal care. Semin Fetal Neonatal Med. 2007 Dec;12(6):482-9.
18. Rintoul NE, Sutton LN, Hubbard AM, Cohen B, Melchionni J, Pasquariello
PS, et al. A new look at myelomeningoceles: functional level, vertebral
level, shunting, and the implications for fetal intervention. Pediatrics.
2002 Mar;109(3):409-13.
19. Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson
MP, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele.
N Engl J Med. 2011 Mar 17;364(11):993-1004.
20. Wataganara T, Ngerncham S, Kitsommart R, Fuangtharnthip P. Fetal neck
myofibroma. J Med Assoc Thai. 2007 Feb;90(2):376-80.
21. Kunisaki SM, Fauza DO, Barnewolt CE, Estroff JA, Myers LB, Bulich LA,
et al. Ex utero intrapartum treatment with placement on extracorporeal
membrane oxygenation for fetal thoracic masses. J Pediatr Surg. 2007
Feb;42(2):420-5.
22. Adzick NS. Open fetal surgery for life-threatening fetal anomalies. Semin
Fetal Neonatal Med. 2010 Feb;15(1):1-8.
23. Galinkin JL, Gaiser RR, Cohen DE, Crombleholme TM, Johnson M,
Kurth CD. Anesthesia for fetoscopic fetal surgery: twin reverse arterial
perfusion sequence and twin-twin transfusions syndrome. Anesth Analg.
2000 Dec;91(6):1394-7.
24. Rosen MA. Anesthesia for fetal procedures and surgery. Yonsei Med J.
2001 Dec;42(6):669-80.
25. Myers LB, Bulich LA, Hess P, Miller NM. Fetal endoscopic surgery:
indications and anaesthetic management. Best Pract Res Clin Anaesthesiol.
2004 Jun;18(2):231-58.
26. Schwartz DA, Moriarty KP, Tashjian DB, Wool RS, Parker RK, Markenson
GR, et al. Anesthetic management of the exit (ex utero intrapartum treatment)
procedure. J Clin Anesth. 2001 Aug;13(5):387-91.
27. Gaiser RR, Cheek TG, Kurth CD. Anesthetic management of cesarean
delivery complicated by ex utero intrapartum treatment of the fetus. Anesth
Analg. 1997 May;84(5):1150-3.
28. George RB, Melnick AH, Rose EC, Habib AS. Case series: Combined
spinal epidural anesthesia for Cesarean delivery and ex utero intrapartum
treatment procedure. Can J Anaesth. 2007 Mar;54(3):218-22.
29. Chang LC, Kuczkowski KM. The ex utero intrapartum treatment procedure:
anesthetic considerations. Arch Gynecol Obstet. 2008 Jan;277(1):83-5.
Downloads
Published
03-04-2020
How to Cite
Wataganara, T. ., Triyasunant, N. ., & Viboonchart, S. . (2020). Fetal Therapy in 2011: A Review. Siriraj Medical Journal, 63(3), 97–101. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/240922
Issue
Section
Special Issue
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
